Anbio Biotechnology (NASDAQ:NNNN) Hits New 52-Week Low – Time to Sell?

Anbio Biotechnology (NASDAQ:NNNN)’s stock price reached a new 52-week low during mid-day trading on Saturday . The stock traded as low as $8.30 and last traded at $9.39, with a volume of 56447 shares. The stock had previously closed at $11.15.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings raised Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, May 14th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Anbio Biotechnology Price Performance

The stock’s fifty day simple moving average is $21.81.

Anbio Biotechnology (NASDAQ:NNNN) last issued its quarterly earnings data on Tuesday, April 7th. The company reported $0.03 EPS for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.